title: Serum level of sCD30 molecule but not sCD30L in patients with psoriasis is reduced by Goeckerman's therapy.
authors.forename: Andrys
authors.initials: A
authors.lastname: Ctirad
authors.forename: Krejsek
authors.initials: K
authors.lastname: Jan
authors.forename: Borska
authors.initials: B
authors.lastname: Lenka
authors.forename: Fiala
authors.initials: F
authors.lastname: Zdenek
authors.forename: Hamakova
authors.initials: H
authors.lastname: Kveta
authors.forename: Belobradek
authors.initials: B
authors.lastname: Michal
authors.forename: Ettler
authors.initials: E
authors.lastname: Karel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D053285:CD30 Ligand / Q000097:blood*; D003033:Coal Tar / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D017730:Ki-1 Antigen / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D014467:Ultraviolet Therapy / Q000379:methods*; D055815:Young Adult
chemical_list: D053285:CD30 Ligand; D007641:Keratolytic Agents; D017730:Ki-1 Antigen; C505774:TNFSF8 protein, human; D003033:Coal Tar